Showing 2,081 - 2,100 results of 2,974 for search '"drug interaction"', query time: 0.19s Refine Results
  1. 2081

    Investigation and Comparison of Diagnosis and Treatment Guidelines for Community Acquired Pneumonia in terms of Pharmaceutical Care Requirements by Melda BAHAP, Emre KARA, Ahmet Görkem ER, Kutay DEMİRKAN, Serhat ÜNAL

    Published 2021-03-01
    “…This review waswritten to compare five CAP guidelines (British Thoracic Society, National Institute for Health and Care Excellence, European Society of Clinical Microbiology and Infectious Diseases, Spanish Pneumology and Thoracic Surgery Association, Turkish Thoracic Society), to identify and discuss their differences, and to discuss the issues not considered in the guidelines such as drug interactions, dose adjustment in kidney/liver dysfunction, dose adjustment in obesity, serious/common side effects, and pharmacokinetic-pharmacodynamic properties of the drugs.…”
    Get full text
    Article
  2. 2082

    Comparative analysis of drug-salt-polymer interactions by experiment and molecular simulation improves biopharmaceutical performance by Sumit Mukesh, Goutam Mukherjee, Ridhima Singh, Nathan Steenbuck, Carolina Demidova, Prachi Joshi, Abhay T. Sangamwar, Rebecca C. Wade

    Published 2023-09-01
    “…However, the effects of polymers on drug-drug interactions in aqueous phase are largely unexplored and it is unclear how to choose an optimal salt-polymer combination for a particular drug. …”
    Get full text
    Article
  3. 2083

    Explainable Artificial Intelligence for Patient Safety: A Review of Application in Pharmacovigilance by Seunghee Lee, Seonyoung Kim, Jieun Lee, Jong-Yeup Kim, Mi-Hwa Song, Suehyun Lee

    Published 2023-01-01
    “…Although artificial intelligence (AI) is actively used in drug surveillance and patient safety, gathering adverse drug reaction information, extracting drug-drug interactions, and predicting effects, XAI is not normally utilized. …”
    Get full text
    Article
  4. 2084

    Strategies for Successful Over-Expression of Human Membrane Transport Systems Using Bacterial Hosts: Future Perspectives by Michele Galluccio, Lara Console, Lorena Pochini, Mariafrancesca Scalise, Nicola Giangregorio, Cesare Indiveri

    Published 2022-03-01
    “…In addition, roughly 60% of FDA-approved drugs interact with membrane proteins, among which are transporters, often responsible for pharmacokinetics and side effects. …”
    Get full text
    Article
  5. 2085
  6. 2086

    Virtual twins for model‐informed precision dosing of clozapine in patients with treatment‐resistant schizophrenia by Sam Mostafa, Reza Rafizadeh, Thomas M. Polasek, Chad A. Bousman, Amin Rostami‐Hodjegan, Robert Stowe, Prescilla Carrion, Leslie J. Sheffield, Carl M. J. Kirkpatrick

    Published 2024-03-01
    “…However, refinement is required to improve the prediction of pharmacokinetic drug–drug interactions, particularly with fluvoxamine augmentation.…”
    Get full text
    Article
  7. 2087

    Prevalence and pattern of use of medications amongst undergraduate students of a Nigerian University by Olubunmi Margaret Ogbodu, Ayobami Precious Adekola, Gloria Thupayagale-Tshweneagae

    Published 2023-01-01
    “…Such practices can lead to increased toxicity, drug interactions, and other adverse effects. This study investigated the prevalence and pattern of use of prescription and OTC medications amongst undergraduate students at the University of Lagos. …”
    Get full text
    Article
  8. 2088
  9. 2089

    Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery by Ri Han, Hongryul Yoon, Gahee Kim, Hyundo Lee, Yoonji Lee

    Published 2023-09-01
    “…Nonetheless, new relationships and methods have been unveiled, demonstrating AI’s expanding potential in predicting and understanding drug interactions and properties. For its full potential to be realized, interdisciplinary collaboration is essential. …”
    Get full text
    Article
  10. 2090

    “The Good, the Bad and the Ugly” in the First Year of COVID-19 Pandemic by Berkay Kapar, Deniz Şimşek, Gülay Sain Güven

    Published 2021-03-01
    “…During the first year of COVID-19 pandemic, while there have been rapid developments in diagnosis and treatment of the disease; drug interactions and side effects have created a problem especially in high risk patients with chronic diseases and multiple drug use. …”
    Get full text
    Article
  11. 2091

    EXPERT EVALUATION OF PRECLINICAL STUDIES OF PRIMARY AND SECONDARY PHARMACODYNAMICS OF MEDICINES by G. N. Engalycheva, R. D. Subaev, D. V. Gorachev, Yu. V. Olefir

    Published 2018-12-01
    “…According to the EAEU Rules of registration and evaluation of medicinal products for human use, the Common  Technical Document has to include information  on primary pharmacodynamics, secondary pharmacodynamics, safety pharmacology  studies, and pharmacodynamic drug interactions, which are subject to evaluation  during examination  of the preclinical  study results. …”
    Get full text
    Article
  12. 2092

    Antifungal Properties of Chemically Defined Propolis from Various Geographical Regions by Marcin Ożarowski, Tomasz M. Karpiński, Rahat Alam, Małgorzata Łochyńska

    Published 2022-02-01
    “…Mechanisms of antifungal activity of propolis extracts and research trends in the aspect of developing new therapies and the assessment of drug interactions are indicated. The review of the research results shows that there is great progress in the definition of propolis extracts. …”
    Get full text
    Article
  13. 2093

    Venous Thromboembolism and Cancer: A Comprehensive Review from Pathophysiology to Novel Treatment by Mario Enrico Canonico, Ciro Santoro, Marisa Avvedimento, Giuseppe Giugliano, Giulia Elena Mandoli, Maria Prastaro, Anna Franzone, Raffaele Piccolo, Federica Ilardi, Matteo Cameli, Giovanni Esposito

    Published 2022-02-01
    “…The selection of patients who have a balanced risk–benefit profile for management of anticoagulation is complex, given individual patient goals and preferences, different prognosis of specific cancers, common comorbidities, potential drug–drug interactions, underweight states, and the competing risks of morbidity and mortality. …”
    Get full text
    Article
  14. 2094

    Pharmacology and Adverse Events of Emergency-Use Authorized Medication in Moderate to Severe COVID-19 by Jen-Yu Hsu, Yan-Chiao Mao, Po-Yu Liu, Kuo-Lung Lai

    Published 2021-09-01
    “…The drug-specific pharmacokinetics, toxicity, and drug interactions are summarized in this study. Remdesivir and baricitinib are small-molecule drugs that are mainly metabolized by the kidneys, while tocilizumab and sarilumab are monoclonal antibody drugs with metabolic pathways that are currently not fully understood. …”
    Get full text
    Article
  15. 2095

    Skin Pigmentation Types, Causes and Treatment—A Review by Amin Mahmood Thawabteh, Alaa Jibreen, Donia Karaman, Alà Thawabteh, Rafik Karaman

    Published 2023-06-01
    “…Albinism, melasma, vitiligo, Addison’s disease, and post-inflammatory hyperpigmentation, which can be brought on by eczema, acne vulgaris, and drug interactions, are the most common skin pigmentation disorders in clinical practice. …”
    Get full text
    Article
  16. 2096
  17. 2097

    An Up-to-Date Article Regarding Particularities of Drug Treatment in Patients with Chronic Heart Failure by Valentina Buda, Andreea Prelipcean, Dragos Cozma, Dana Emilia Man, Simona Negres, Alexandra Scurtu, Maria Suciu, Minodora Andor, Corina Danciu, Simina Crisan, Cristina Adriana Dehelean, Lucian Petrescu, Ciprian Rachieru

    Published 2022-04-01
    “…The article also highlights several drugs and food supplements that may worsen the prognosis of HF patients and discusses some potential drug–drug interactions, their consequences and recommendations for health care providers, as well as the risks of adverse drug reactions and treatment discontinuation, as an interdisciplinary approach to treatment is essential for HF patients.…”
    Get full text
    Article
  18. 2098

    Placental efflux transporters and antiseizure or antidepressant medication use impact birth weight in MoBa cohort by Marta H. Hernandez, Jacqueline M. Cohen, Karoline H. Skåra, Thea K. Grindstad, Yunsung Lee, Per Magnus, Pål R. Njølstad, Ole A. Andreassen, Elizabeth C. Corfield, Alexandra Havdahl, Espen Molden, Kari Furu, Maria C. Magnus, Alvaro Hernaez

    Published 2024-03-01
    “…Antidepressant exposure was associated with low birth weight, but there were no gene-drug interactions. The interplay between MRP2-ABCC2 and MDR1-ABCB1 variants and antiseizure medication may impact neonatal birth weight.…”
    Get full text
    Article
  19. 2099

    Positive kidney profile of dogs with Leishmania sp. and treated with miltefosine by Danillo Brenno de Assis Torres, Nelson Costa Pinheiro, Ellis Sousa Barros, Dennis Leite dos Santos, José Ribamar da Silva Júnior, Porfírio Cadanedo Guerra

    Published 2024-03-01
    “…To stage the disease and carry out treatment, kidney assessment is of great importance, along with drug interactions and the deposition of immune complexes. …”
    Get full text
    Article
  20. 2100

    Pharmacists’ Role in Managing Patients with Chronic Lymphocytic Leukemia by Kevin Y. Chen, Kelly M. Brunk, Bianka A. Patel, Kurtis J. Stocker, Jessica J. Auten, Kaitlyn M. Buhlinger, Benyam Muluneh

    Published 2020-03-01
    “…This paradigm shift poses new challenges for the medical team, including drug–drug interactions, adherence counseling, and financial toxicity. …”
    Get full text
    Article